Atlas Trials

DCE-MRI Using Dotarem® in Evaluation of Therapeutic Response to Sorafenib in Patients With Advanced Stage HCC

Clinical trial NCT01806740 · TERMINATED

Trial details

NCT number
NCT01806740
Sponsor
Guerbet
Status
TERMINATED
Phase
Phase 4
Study type
INTERVENTIONAL
Hepatocellular Carcinoma
Start date
2013-05-09
Primary completion
2015-10-12
Enrollment
37

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.